Replies to post #690851 on NorthWest Biotherapeutics Inc (NWBO)

[jesster64]

Agreed. I think bump in SP on UK approval, but only 2-3$, then walkdown in price again because of media blackout when they submit to FDA. I have no faith in lawsuit of short squeeze. But MHRA approval begins the snowball rolling downhill. Revenue rolling in and more combo trials. But I stopped believing in quick 20$ a share buyout. In the long run, it will be worth much more with partnerships, especially when keytruda patent expires. So patience. But 4x investment when MHRA approval, at least we got that going for us, gonga, la gonga in the words of the dali lama.